These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 367975)
1. Pirbuterol in the treatment of bronchial asthma. Beumer HM Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):18-25. PubMed ID: 367975 [TBL] [Abstract][Full Text] [Related]
2. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma. Beumer HM Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220 [TBL] [Abstract][Full Text] [Related]
3. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma. Littner MR; Tashkin DP; Calvarese B; Bautista M Ann Allergy; 1982 Jan; 48(1):14-20. PubMed ID: 7055342 [No Abstract] [Full Text] [Related]
4. Long-term treatment of bronchial asthma with pirbuterol aerosol. Beumer HM Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):172-5. PubMed ID: 6862719 [TBL] [Abstract][Full Text] [Related]
5. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma. Beumer HM Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262 [TBL] [Abstract][Full Text] [Related]
6. Fenoterol: clinical trial of a new long acting bronchodilator. Emirgil C; Palmer K; VanVoorhies L; Wesson C; Sobol BJ Ann Allergy; 1977 Dec; 39(6):415-7. PubMed ID: 339786 [TBL] [Abstract][Full Text] [Related]
7. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol. Ence TJ; Tashkin DP; Ho D; Child JS Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600 [TBL] [Abstract][Full Text] [Related]
8. Double-blind, crossover comparison of carbuterol and salbutamol. Guleria JS; Vasu KV; Pande JN Ann Allergy; 1979 Aug; 43(2):123-5. PubMed ID: 380412 [TBL] [Abstract][Full Text] [Related]
9. Pyrbuterol: a new bronchodilator. Phase I-single dose study. Steen SN; Ziment I; Thomas JS Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618 [No Abstract] [Full Text] [Related]
10. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma. Brandon ML Ann Allergy; 1980 Jul; 45(1):8-12. PubMed ID: 7406244 [TBL] [Abstract][Full Text] [Related]
11. Long-term oral bronchodilator therapy of asthma with pirbuterol. Burki NK; Diamond L Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723 [TBL] [Abstract][Full Text] [Related]
12. A clinical comparison of subcutaneous doses of Terbutaline and adrenaline in bronchial asthma. Nõu E Scand J Respir Dis; 1971; 52(4):192-8. PubMed ID: 4949816 [No Abstract] [Full Text] [Related]
13. [Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)]. Cornudella R; Castellano A; Santafé G Rev Clin Esp; 1973 Jun; 129(5):469-76. PubMed ID: 4732991 [No Abstract] [Full Text] [Related]
14. Bronchodilator combinations in animals and in man. Mattila MJ; Salonen RO; Ruotsalainen EM Ann Clin Res; 1985; 17(3):120-2. PubMed ID: 3901875 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral terbutaline in asthmatic patients. A dose response study. Fagerberg E; Tegner KB Scand J Respir Dis; 1972; 53(1):3-9. PubMed ID: 4559526 [No Abstract] [Full Text] [Related]
16. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol. Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. Mazza JA; Tashkin DP; Reed CE Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine. Dulfano MJ; Glass P Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567 [No Abstract] [Full Text] [Related]
19. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction. Poppius H; Lehti H; Stenius-Aarniala B Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417 [TBL] [Abstract][Full Text] [Related]
20. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices. Tinkelman DG; Lutz C Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]